期刊文献+

喉癌组织中树突状细胞抑癌基因p63和金属蛋白酶组织抑制因子-1表达的意义 被引量:3

Expression of S-100 positive dendritic cell, TIMP-1 and p63 and its significcerce in the primary laryngeal carcinoma
原文传递
导出
摘要 目的:探讨树突状细胞(S 100)、抑癌基因p63、金属蛋白酶组织抑制因子 1(TIMP 1)在喉癌组织中 的表达及与吸烟、饮酒、病理学分级、临床TNM分期和预后等因素的关系。方法:应用组织芯片技术和免疫组织 化学SP法检测85例喉鳞状细胞癌组织中S 100、p63、TIMP 1等因子的表达。结果:85例中,6例组织芯片脱落 或无肿瘤细胞。对79例进行S 100检测,其中47例(59.5%)出现阳性细胞(0~34个/视野)。S 100阳性树突状 细胞浸润程度与喉癌分化程度、临床分期差异均有统计学意义(均P<0.05)。对79例进行TIMP 1检测,其中 35例(44.3%)为阴性表达,44例(55.7%)为阳性表达。TIMP 1蛋白阳性表达与患者肿瘤临床分期、有无淋巴结 转移及预后差异均有统计学意义(均P<0.05)。在79例中,58例p63表达阳性(73.4%),平均染色比率为 45.5%,但未发现与临床因素相关。结论:TIMP 1、S 100与肿瘤的生长、分化有关,可作为临床检测预后的重要 参考指标。 Objective:To evaluate the predictive role of S-100 positive dendritic cell, tissue inhibitor of metalloproteinases-1 (TIMP-1) and p63 gene in primary laryngeal carcinoma with epidemiology(smoking and drinking), histological grading, surgical treatment,TNM stage and prognosis by the tissuechip technology. Method:We studied the expression of dendritic cell(S-100), TIMP-1 and p63 gene on a series of 85 primary laryngeal carcinoma patients who had ever received in our hospital between 1992 and 2000 by the tissuechip technology and SP method.The correlation of each score according to the intensity and percentage of labeled cells or intercellular substance with relevant clinical dada was statistically analyzed. Result:Some cases were lost or boasted no tumor tissue in our tissuechip. In available 79 patients, the rate of expressing S-100 positive dendritic cell is 59.5% (47/79), and the average percentage of its labeled cells in them is 8.71%.S-100 positive dentritic cells showed significent difference among different pathological grade group,early and late stage(P<0.05). The rate is 55.7%(44/79) of the specimens whose basal membrane and extracellular matrix was strongly stained by TIMP-1;There was statistical significand in TIMP-1 protein demonstration between early and late stages, lymph node metastasis and 3-year survival rate (P<0.05) by chi-square test, but no relation with smoking, drinking, gender, age and histological classes (P>0.05).There was wo statistical significand in p63 protein demonstration between TNM stages, lymph node metastasis, 3-year survival rate, smoking, drinking, gender, age and histological classes (P>0.05). Conclusion:The tissue microarray technique spent shorter time and less expense, and showed higher consistency in our essays. And the present study suggests TIMP-1 and S-100 conld be the clinical discriminators in laryngeal carcinoma.
出处 《临床耳鼻咽喉科杂志》 CSCD 北大核心 2005年第3期127-129,共3页 Journal of Clinical Otorhinolaryngology
基金 上海市科委基金资助项目(No:市4119181)
关键词 喉肿瘤 免疫组织化学 树突状细胞 抑癌基因 金属蛋白酶组织抑制因子-1 Laryngeal neoplasms Immunohistochemistry Dendritic cell p63 gene Tissue inhibitor of metalloproteinases-1
  • 相关文献

参考文献4

  • 1杨海宁.P53蛋白家族的研究进展[J].国外医学(生理病理科学与临床分册),2002,22(2):116-118. 被引量:2
  • 2Hamada I,kato M,Yamasaki T,et al.Clinical effects of tumor-associated macrophages and dendritic cells on renal carcinoma.Anticancer Res,2002,22:4281-4284.?A?A
  • 3Tsujitani S, Kakeji Y, Watanabe A, et al. Infiltration of dendritic cells in relation to tumor invasion and lymph node metastasis in human gastric cancer. Cancer,1990,66:2012-2019.
  • 4Kugler A. Matrix metalloproteinases and their inhibitors.Anticancer Res, 1999,19:1589-1592.

二级参考文献36

  • 1Attardi LD. The role of p53 in tumour suppression: lessons from mouse models[J]. Cell Mol Life Sci, 1999, 55:48-63.
  • 2Chen X. The p53 family: same response, different signals[J]? Mol Med Today, 1999, 5: 387-392.
  • 3Kaelin WG. The p53 gene family[J]. Oncogene, 1999, 18:7701-7705.
  • 4Yang A, Schweitzer R, Sun D, et al. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development[J]. Nature, 1999, 398: 714-717.
  • 5Mills AA, Zheng B, Wang X J, et al. p63 is a p53 homologue required for limb and epidermal morphogenesis[J]. Nature, 1999, 398: 708-713.
  • 6Celli J, Duijf P, Hame BC, et al. Heterozygous germline mutations in the p53 homolog p63 are the cause of EEC syndrome[J]. Cell, 1999,99: 143-153.
  • 7Yang A, Walker N, Bronson R, et al. p73-deficient mice have neurological, phermonal and inflammatory defects but lack spontaneous tumours[J]. Nature, 2000, 404: 99-103.
  • 8Chi SW, Ayed A, Arrowsmith CH, et al. Solution structure of a conserved C-terminal domain of p73 with structural homology to the SAM domain[J]. EMBO J, 1999, 18: 4438-4445.
  • 9Zhu J, Zhou W, Jiang J, et al. Identification of a novel p53 functional domain that is necessary for mediating apoptosis [ J ]. J Biol Chem,1998, 273: 13030-13036.
  • 10Bates S, Vousden KH. Mechanisms of p53-mediated apoptosis[J]. Cell Mol Life Sci, 1999, 55: 28-37.

共引文献1

同被引文献18

  • 1Karakok M,Bayazit Y A,Ucak R,et al.Langerhans cell related inflammatory reaction in laryngeal squamous cell carcinoma.Auris Nasus Larynx,2003,30:81-84.
  • 2Sprinzl G M,Hussl B,Obrist P,et al.Dendritic Cells in Precancerous Lesions of the Larynx.Laryngoscope,2000,110:13-18.
  • 3Chang C C,Wright A,Punnonen J.Monocyte-derived CD1a^+ and CD1a-dendritic celll subsets different in their cytokine production profiles,susceptibilities to transfection,and capacities to direct th cell differntiation.J Immunology,2000,165:3584-3591.
  • 4Fong L, Engleman E G. Dendritic cells in cancer immunotherapy. Annu Rev Immunol, 2000,18 : 245-273.
  • 5Hobbs J R. Immunotherapy of human cancers., new approaehes hold out promise. Br Med J, 1989,299:1174-1174.
  • 6Boczkowski D, Nair S K, Snyder D, et al. Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vlvo. J Exp Med,1996, 184:465--472.
  • 7Vollmer C M, Eilber F C, Butterfiels L H, et al. Alpha Fetoprotein-specific immunotherapy for Hepatocellular Carcinoma. Cancer Res, 1999,59 : 3064-3067.
  • 8Butterfield L H, Koh A, Meng W, et al. Generation of human T eell responses to an HLA-A2. 1-restrieted peptide epitope from Alpha Fetoprotein. Caneer Res,1999,59:3134--3142.
  • 9Amigorena S. Anti-tumour immunotherapy using dendritic-cell-derived exosomes. Immunol Rev. 1998. 165:39-46.
  • 10Zitvogel L,Regnault A,Lozier A,et al.Eradication of established murine tumors using a novel cell-free vaccine:dendritic cell-derived exosomes.Nat Med,1998,4:594-600.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部